CRN meets FDA on NDIs: We won’t budge on synthetics but there may be middle ground elsewhere
Food and Drug Administration (FDA) officials were “engaged” and “receptive” during a meeting with the Council for Responsible Nutrition (CRN) this week about its controversial draft guidance on new dietary ingredients (NDIs), says the CRN.